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Flow mediated dilatationAbstract Background: Cigarette smoking is a well known risk factor for cardiovascular disease,
however, little is known regarding water pipe (WP) smoking. High sensitivity C-reactive protein
(hs-CRP) and ﬂow mediated dilatation (FMD) are well recognized methods to assess cardiovascular
risks.
Objectives: To study the effect of WP smoking on hs-CRP level and endothelial function compared
to cigarette smoking.
Methods: The study included 77 male subjects (30 WP smokers, 30 cigarette smokers, and 17 con-
trols). Hs-CRP level was measured using the ELISA technique and the threshold of high risk level
was 3 mg/l. FMD was assessed in the brachial artery. Subjects with FMD< 10% were considered
to have endothelial dysfunction. The composite of high risk hs-CRP level and endothelial dysfunc-
tion was considered as high risk proﬁle.
Results: Hs-CRP level was slightly higher in smokers than controls (2.21 ± 1.6 versus
1.73 ± 1.19 mg/l, P= 0.25). FMD was signiﬁcantly lower in smokers (12 ± 6.66 versus
17.45 ± 11.29%, P= 0.016). There were no signiﬁcant differences between WP smokers and cig-
arette smokers regarding hs-CRP level (P= 0.19) and FMD (P= 0.91). In an adjusted regression
234 O.A. Diab et al.model, age (P= 0.002) and cigarette smoking (P= 0.046) were found to be signiﬁcant predictors
for high risk proﬁle, whereas WP smoking did not have a predictive effect (P= 0.91).
Conclusions: WP smokers and cigarette smokers had comparable degrees of inﬂammation and
endothelial dysfunction. However, cigarette smoking was a stronger predictor for high risk proﬁle.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Cardiology.Figure 1 Simple illustration of water pipe showing water pipe
head (WPH) containing the tobacco (left) being exchanged when
consumed (right).1. Introduction
Water pipe (WP) tobacco smoking (other terms are hookah,
shisha, nargile, arghile and hubble bubbleis) is gaining wide
popularity among young and middle aged males and females.
Available evidence suggests that the prevalence of WP smok-
ing ranged from 6% to 34% among Middle Eastern adoles-
cents, 5–17% among American adolescents, and that WP use
is increasing globally.1 Studies on the cardiovascular effects
of WP smoking are limited by methodological quality, the nov-
elty of WP epidemic relative to cigarettes, and the highly var-
iable WP tobacco contents.
Inﬂammation and endothelial dysfunction are integral com-
ponents for the initiation and progression of atherosclerosis.
These components precede the clinical manifestations of
atherosclerosis and cardiovascular events. High sensitivity C
reactive protein (hs-CRP) has been described as an inﬂamma-
tory biomarker linked to cardiovascular risk factors and cardiac
events.2,3 An hs-CRP level of >3 mg/l was independently asso-
ciated with a 60% excess risk of incident coronary artery disease
(CAD) as comparedwith levels<1 mg/l after adjustment for all
Framingham risk variables.4 Flow mediated dilatation (FMD);
another predictor of cardiovascular risks, is a measure of nitric
oxide (NO) mediated endothelial function that reﬂects the
hyperemic response of the brachial artery to sheer stress.5,6 Cig-
arette smoking has been recognized to be associated with
inﬂammation and impaired endothelial function,7 but little is
known regarding WP smoking.
Although several in vitro studies compared WP to cigarette
smoke, there are little data regarding the in vivo effect of either
type of smoking. Furthermore, WP tobacco is highly variable
in content and processing. The apple ﬂavored WP tobacco,
despite its popularity, was not well characterized in clinical
studies.
2. Methods
The study enrolled 77 apparently healthy males including 60
smokers (durationP 5 years) and 17 non smokers as a control
group. Smokers were divided into 30 WP smokers and 30 cig-
arette smokers. WP smoking was uniﬁed to include only apple
ﬂavored WP tobacco. We used the term ‘‘water pipe head’’
(WPH) to describe a single smoking ration (Fig. 1). Several
rations may be consumed by WP smoker during a single
smoking session.
Exclusion criteria included mixed PW and cigarette
smoking, age >60 years, evidence or suspicion of CAD,
cerebrovascular or peripheral vascular disease, hypertension
(HTN), diabetes mellitus (DM), hypercholesterolemia,
acute or chronic inﬂammatory disease, malignancy, recent
surgery, antiinﬂammatory drug intake, and hs-CRP levels
>10 mg/l.All subjects were assessed by history and clinical examina-
tion, 12-lead surface electrocardiogram (ECG), random blood
sugar, total cholesterol, hs-CRP, and FMD. History taking
emphasized on smoking duration (years), number of WPHs
or cigarettes consumed per day, and number of lifetime totally
smoked WPHs or cigarettes calculated as number of WPHs or
cigarettes/day multiplied by 365 multiplied by smoking dura-
tion (years).
2.1. High sensitivity CRP
It was measured by enzyme linked immunosorbent assay
(ELISA). Hs-CRP levels were classiﬁed as low risk (<1 mg/
l), intermediate risk (1–3 mg/l), and high risk (>3 mg/l).8,9
2.2. Flow mediated dilatation
It was measured by a non invasive method to evaluate ﬂow
mediated dilatation as an endothelium dependant vasoregula-
tory function in the brachial artery. Steps of measurement
included:10,11
2.2.1. Subject preparation
Measurement was done during the fasting state for 8–12 h in a
quiet, temperature-controlled room (22–24 C). All vasoactive
medications were withheld for at least four half lives. Subjects
avoided exercise and withheld caffeine, high-fat food, vitamin
C, and tobacco for at least 4–6 h before the study.
2.2.2. Equipment
Linear array transducer with a minimum frequency of 7 MHz,
attached to a high-quality mainframe ultrasound system was
used to acquire images with sufﬁcient resolution for
subsequent analysis. Image resolution was enhanced with
broadband (multiple-frequency: 7–12 MHz) linear array
Figure 2 B-mode image of the brachial artery. Left: baseline image. Right: during hyperemia (D2  D1 = 0.1 mm, FMD= 2.5%, case
No. 2 among cigarette smokers).
Waterpipe Smoking versus Cigarette Smoking 235transducers. Timing of each image frame with respect to the
cardiac cycle was determined with simultaneous ECG.
2.2.3. Image acquisition (Fig. 2)
Subjects were positioned in supine position. To create a ﬂow
stimulus in the brachial artery, a sphygmomanometer cuff
was ﬁrst placed above the antecubital fossa, with the arm in
a comfortable position for imaging the brachial artery above
the antecubital fossa in the longitudinal plane using B-mode.
A segment with clear anterior and posterior intimal interface
between the lumen and vessel wall was selected for continuous
2D grayscale imaging. A baseline resting image was acquired
then arterial occlusion was created by cuff inﬂation to
50 mmHg above systolic pressure for 5 min. Subsequent cuff
deﬂation induced a high ﬂow state through the brachial artery
(reactive hyperemia). The resulting increase in shear stress
caused the brachial artery to dilate. The maximum vessel diam-
eter was measured 60 s after deﬂation of the cuff. FMD was
calculated as:
FMD ð%Þ¼ ½ðD2D1Þ=D1100 ðD2 is the reactive
hyperemic diameter;D1 is the baseline diameterÞ:2.3. Deﬁnitions
‘‘High risk hs-CRP level’’ was deﬁned as hs-CRP of more than
3 mg/l.8,9 ‘‘Endothelial dysfunction’’ was deﬁned as FMD of
<10%.12,13 ‘‘High risk proﬁle’’ was deﬁned as the composite
of high risk hs-CRP level and endothelial dysfunction.
‘‘Absolute hyperemic change’’ was deﬁned as the absolute
increase in brachial diameter in millimeters (D2  D1).
2.4. Statistical analysis
Statistical Package for Social Sciences (SPSS version 15.0) was
used. Categorical data were expressed as frequencies and
percentages, while continuous data were expressed asmean ± SD. D’Agostino–Pearson test was used to test the
normality of continuous data. Comparison between categori-
cal data was done using Fisher’s exact test or Chi square as
appropriate, while comparison between continuous data was
done using the unpaired t-test or Mann–Whitney test as appro-
priate. Correlations were made using Pearson’s correlation
coefﬁcient or Spearman’s rho as appropriate. Univariate and
multivariate logistic regression analyses were used to deter-
mine predictors of high risk hs-CRP level, endothelial dysfunc-
tion, or both. P value was considered signiﬁcant if <0.05.
3. Results
3.1. Baseline characteristics
All of the included subjects were males, none of whom had a
history of HTN, DM, known or symptoms suggestive of
CAD, cerebrovascular or peripheral vascular disease. None
of the included subject was on any medications. There were
no signiﬁcant differences between the 3 study groups regarding
clinical characteristics as shown in Table 1.
Smoking duration was 8.13 ± 2.37 (range 5–14) years in
WP smokers, and 12.96 ± 6.17 (range 5–30) years in cigarette
smokers, being signiﬁcantly longer in the latter group
(P< 0.0001). WP smokers consumed 5.2 ± 1.84 (range
2–10) WPHs/day and the number of totally smoked WPHs
was 16084.33 ± 8654.44 (range 5110–36,500). Cigarette smok-
ers consumed 25.73 ± 7.8 (range 15–40) cigarettes/day and the
number of totally smoked cigarettes was 125304.5 ± 71307.49
(range 27,375–273,750).
3.2. Smokers versus non smokers
Smokers (including both WP and cigarette smokers) had a
slightly higher hs-CRP level than non smokers that was statis-
tically non-signiﬁcant. Absolute hyperemic change (D2  D1)
and FMD were signiﬁcantly smaller in smokers than controls
Table 1 Baseline characteristics.
WP smokers n= 30 Cigarette smokers n= 30 Non smokers n= 17 P-value
Age (yrs) 34.86 ± 8.93 35.16 ± 10.91 35.52 ± 10.33 0.97
FH of CAD (+ve, ve) 18, 12 19, 11 9, 8 0.78
Weight (kg) 78.96 ± 11.38 75.16 ± 10.17 79.08 ± 10.82 0.31
Height (cm) 175 ± 7.83 172.83 ± 7.59 174.82 ± 9.06 0.53
BMI 25.74 ± 2.68 25.14 ± 2.64 25.72 ± 2.65 0.63
HR (bpm) 78.1 ± 4.96 77.86 ± 6.174 76.23 ± 5.58 0.52
SBP (mmHg) 122 ± 7.61 117.33 ± 7.84 119.41 ± 7.47 0.069
DBP (mmHg) 79.66 ± 4.13 76.66 ± 5.46 77.05 ± 6.85 0.07
WP: water pipe. FH: family history. CAD: coronary artery disease. BMI: body mass index. HR: heart rate. SBP: systolic blood pressure. DBP:
diastolic blood pressure.
Table 2 High sensitivity CRP and FMD in smokers versus non smokers.
Smokers n= 60 Non smokers n= 17 P-value
Hs-CRP (mg/l) 2.21 ± 1.6 1.73 ± 1.19 0.25
Hs-CRP levels (No.)
<1 mg/l 11 5 0.51
1–3 mg/lx 38 10 0.95
>3 mg/l 11 2 0.78
D1 (mm) 3.8 ± 0.5 3.93 ± 0.45 0.34
D2 (mm) 4.25 ± 0.57 4.61 ± 0.59 0.027
D2  D1 (mm) 0.45 ± 0.25 0.67 ± 0.42 0.013
FMD (%) 12 ± 6.66 17.45 ± 11.29 0.016
FMD< 10% (No.) 24 2 0.03
Hs-CRP: high sensitivity C-reactive protein. D1: basal brachial artery diameter. D2: hyperemic brachial artery diameter. FMD: ﬂow mediated
dilatation.
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(FMD< 10%) was higher in smokers (OR: 5, 95% CI: 1.04–
23.87, P= 0.03).
Multivariate analysis showed that smoking did not predict
a high risk hs-CRP level (OR: 2.2, 95% CI: 0.33–14.9,
P= 0.41), while increasing age (at 1 year increment) could
independently predict a high risk hs-CRP level (OR: 1.07,
95% CI: 1.003–1.15, P= 0.04). Regarding FMD, smoking
(OR: 6.34, 95% CI: 1.19–33.5, P= 0.03) and increasing age
(OR: 1.07, 95% CI: 1.02–1.13, P= 0.008) were the only inde-
pendent predictors for endothelial dysfunction.
There was no correlation between hs-CRP and FMD
(P= 0.27) or the absolute hyperemic change (P= 0.26).
3.3. WP smokers versus non smokers
Hs-CRP level was higher in WP smokers than non smokers
but the difference was not statistically signiﬁcant (Table 3).
The number of subjects regarding different hs-CRP risk cate-
gories also did not differ between the 2 groups. There was
no difference in basal brachial diameter, while there was a sig-
niﬁcant difference in hyperemic diameter, absolute hyperemic
change, and FMD. The number of subjects with FMD of
<10% was not signiﬁcantly different between both groups.
3.4. Cigarette smokers versus non smokers
Hs-CRP level was higher in cigarette smokers than non smok-
ers but the difference was not statistically signiﬁcant (Table 4).Although there was no signiﬁcant difference in FMD, the
absolute hyperemic change (D2  D1) was signiﬁcantly lower
in cigarette smokers. The number of subjects with
FMD< 10% was signiﬁcantly higher in cigarette smokers
(OR = 5.73, 95% CI: 1.11–29.64, P= 0.026).
3.5. WP smokers versus cigarette smokers
There were no signiﬁcant differences between the 2 groups
regarding the hs-CRP level and its risk categories. There were
also no differences regarding FMD and number of subjects
with FMD< 10% (Table 5).
3.6. Subjects at high risk
Among the study sample, 34 subjects had either hs-CRP level
>3 mg/l (13 subjects) or FMD< 10% (26 subjects) or both (5
subjects) and were considered to have high risk proﬁle. Each of
WP smoking, cigarette smoking, age, BMI, HR, SBP, DPB
were listed as possible predictors for high risk proﬁle in a logis-
tic regression model (Table 6). Unadjusted regression analysis
showed that age (at 1 year increment) and SBP (at 1 mmHg
increment) were signiﬁcant predictors (P< 0.0001 and 0.018
respectively).
After adjusting for age, BMI, HR, SBP, DPB, and D1,
smoking was found to be a signiﬁcant predictor (OR: 7.13,
95% CI: 1.36–37.38, P= 0.02) for high risk proﬁle. Cigarette
smoking had signiﬁcant predictive effect (OR: 2.99, 95% CI:
1.02–8.8, P= 0.046), whereas WP smoking did not have
Table 3 Comparison between WP smokers and non smokers.
WP smokers n= 30 Non smokers n= 17 P-value
Hs-CRP (mg/l) 2.31 ± 1.34 1.73 ± 1.19 0.14
Hs-CRP levels (No.)
<1 mg/l 4 5 0.25
1–3 mg/l 19 10 0.76
>3 mg/l 7 2 0.45
D1 (mm) 3.76 ± 0.46 3.93 ± 0.45 0.22
D2 (mm) 4.24 ± 0.54 4.61 ± 0.59 0.037
D2  D1 (mm) 0.48 ± 0.29 0.67 ± 0.42 0.033
FMD (%) 12 ± 5.94 17.45 ± 11.29 0.035
FMD< 10% (No.) 11 2 0.094
WP: water pipe. Hs-CRP: high sensitivity C-reactive protein. D1: basal brachial artery diameter. D2: hyperemic brachial artery diameter. FMD:
ﬂow mediated dilatation.
Table 4 Comparison between cigarette smokers and non smokers.
Cigarette smokers n= 30 Non smokers n= 17 P-value
Hs-CRP (mg/l) 2.11 ± 1.84 1.73 ± 1.19 0.65
Hs-CRP levels (No.)
<1 mg/l 7 5 0.73
1–3 mg/l 19 10 0.76
>3 mg/l 4 2 1.00
D1 (mm) 3.84 ± 0.55 3.93 ± 0.45 0.58
D2 (mm) 4.26 ± 0.6 4.61 ± 0.59 0.047
D2  D1 (mm) 0.43 ± 0.22 0.67 ± 0.42 0.019
FMD (%) 12.19 ± 7.42 17.45 ± 11.29 0.06
FMD< 10% (No.) 13 2 0.026
Hs-CRP: high sensitivity C-reactive protein. D1: basal brachial artery diameter. D2: hyperemic brachial artery diameter. FMD: ﬂow mediated
dilatation.
Table 5 Comparison between WP smokers and cigarette smokers.
WP smokers n= 30 Cigarette smokers n= 30 P-value
Hs-CRP (mg/l) 2.31 ± 1.34 2.11 ± 1.84 0.19
Hs-CRP levels (No.)
<1 mg/l 4 7 0.31
1–3 mg/l 19 19 1.00
>3 mg/l 7 4 0.31
D1 (mm) 3.76 ± 0.46 3.84 ± 0.55 0.53
D2 (mm) 4.24 ± 0.54 4.26 ± 0.6 0.88
D2  D1 (mm) 0.48 ± 0.29 0.43 ± 0.22 0.79
FMD (%) 12 ± 5.94 12.19 ± 7.42 0.91
FMD< 10% (No.) 11 13 0.59
WP: water pipe. Hs-CRP: High sensitivity C-reactive protein. D1: basal brachial artery diameter. D2: hyperemic brachial artery diameter.
FMD: ﬂow mediated dilatation.
Waterpipe Smoking versus Cigarette Smoking 237predictive effect on high risk proﬁle (1.05, 95% CI: 0.38–2.9,
P= 0.91). Age remained to be a signiﬁcant predictor after
adjusting for other confounders.
Whether smoking rate (number of WPHs or cigarettes/
day), smoking duration, or totally smoked WPHs or cigarettes
have an inﬂuence on the predictive effect of either type of
smoking on high risk proﬁle, each of these variables was
included in separate regression models for each of WP smokers
and cigarette smokers. Among WP smokers, number of
WPHs/day (P= 0.22), smoking duration (P= 0.86), and
number of totally smoked cigarettes (P= 0.31) did not predicthigh risk proﬁle. Among cigarette smokers, number of ciga-
rettes/day (P= 0.79), smoking duration (P= 0.75), and num-
ber of totally smoked cigarettes (P= 0.6) also did not predict
high risk proﬁle.
3.7. Cumulative effect of smoking on hs-CRP and FMD
Among WP smokers; smoking duration, number of WPHs/
day, and number of totally smoked WPHs did not correlate
with hs-CRP (Table 7). However, smoking duration correlated
signiﬁcantly with FMD (P= 0.015).
Table 6 Predictors of high risk proﬁle (deﬁned as the composite of high risk hs-CRP level and endothelial dysfunction).
Unadjusted odds ratio (95% CI) P-Value Adjusted odds ratio (95% CI)* P-value
Smoking 3.25 (0.95–11.1) 0.06 7.13 (1.36–37.38) 0.02
WP smoking 0.84 (0.33–2.1) 0.72 1.05 (0.38–2.9) 0.91
Cigarette smoking 1.84 (0.72–4.6) 0.19 2.99 (1.02–8.8) 0.046
Age 1.13 (1.05–1.21) <0.0001 1.15 (1.05–1.26) 0.002
BMI 1.04 (0.87–1.23) 0.63 0.87 (0.66–1.14) 0.32
HR 0.97 (0.89–1.05) 0.52 0.93 (0.83–1.04) 0.23
SBP 1.08 (1.01–1.15) 0.018 1.03 (0.93–1.14) 0.5
DBP 1.07 (0.98–1.17) 0.09 1.004 (0.88–1.14) 0.94
D1 2.15 (0.83–5.5) 0.11 1.11 (0.32–3.8) 0.86
WP: water pipe. BMI: body mass index. HR: heart rate. SBP: systolic blood pressure. DBP: diastolic blood pressure. D1: basal brachial artery
diameter.
* Increments of confounders: age (1 year), BMI (1 unit), HR (1 bpm), BP (1 mmHg), D1 (1 mm).
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cigarettes/day, and number of totally smoked cigarettes corre-
lated signiﬁcantly with hs-CRP, while FMD did not show such
correlations.
4. Discussion
4.1. Subject selection
Due to the highly variable WP tobacco content and its process-
ing, we restricted the study to the apple ﬂavored WP tobacco,
being one of the most popular. Apart from family history, the
exclusion of other risk factors of atherosclerosis might help
recognize the effect of smoking and its type with less con-
founding. To advise for cessation of apple ﬂavored WP smok-
ing or to consider it as an unsafe alternative to cigarette
smoking, it was important to make a clinical evidence. The
present study demonstrates the effect of either type of smoking
on two important prognostic factors that represented surro-
gate endpoints for cardiovascular disease; hs-CRP8,9 and
FMD.11–13Table 7 Factors correlated with hs-CRP and FMD among WP an
WP smokers
Smoking
duration
Number of
WPHs/day
Number of
smoked WP
HS-CRP
Correlation
coeﬃcient
0.2 0.13 0.24
P-value 0.28 0.47 0.19
D2  D1
Correlation
coeﬃcient*
0.31 0.01 0.16
P-value 0.08 0.92 0.37
FMD
Correlation
coeﬃcient
0.43 0.12 0.33
P-value 0.015 0.51 0.07
Hs-CRP: High sensitivity C-reactive protein. D1: Basal brachial artery dia
dilatation. HR: Heart rate. SBP: Systolic blood pressure. DBP: diastolic
* Correlation was made using Spearman’s rho due to non-normality.4.2. Hs-CRP
In the largest analysis to date, the discrimination by hs-CRP in
at-risk individuals was limited to men.3 In the present study,
although not reaching statistical signiﬁcance, hs-CRP level
was higher in smokers (2.21 ± 1.6 mg/l) than non smokers
(1.73 ± 1.19 mg/l). Several studies have demonstrated a signiﬁ-
cant association between smoking and elevated hs-CRP lev-
els.14–17 However, one study did not ﬁnd a signiﬁcant
difference in hs-CRP level between smokers and non smokers
although smoking status did correlate with a signiﬁcant eleva-
tion in other inﬂammatory biomarkers.18 The explanation of
these discrepant ﬁndings may be the inclusion of passive smok-
ers among the groups labeled as non smokers, the presence of
subclinical inﬂammation among the smoker groups, the ﬂuctu-
ating behavior of plasma hs-CRP levels, and possible genetic
polymorphism.3,19
Increasing age was the only independent predictor for high
risk hs-CRP level in the present study (P= 0.04). Other stud-
ies also demonstrated a concordant relationship between age
and plasma CRP concentration.20,21 In a study, the mean hs-
CRP level was 3.5 mg/l in 20- to 29-year-old versus 5.7 mg/ld cigarette smokers.
Cigarette smokers
totally
Hs
Smoking
duration
Number of
cigarettes/day
Number of totally
smoked cigarettes
0.62 0.4 0.7
<0.0001 0.027 <0.0001
0.19 0.06 0.14
0.29 0.71 0.43
0.14 0.1 0.13
0.45 0.59 0.46
meter. D2: Hyperemic brachial artery diameter. FMD: Flow mediated
blood pressure. BMI: Body mass index. WPUs: Water pipe units.
Waterpipe Smoking versus Cigarette Smoking 239in 70–79 year-old individuals.2 Such a relationship can be par-
tially explained by the increasing atherosclerotic process with
age that adds cumulative inﬂammatory burden.
4.3. Endothelial function
Flow mediated dilatation is considered the principal measure-
ment of the vasoregulatory endothelial function.10 Our deﬁni-
tion of endothelial dysfunction as an FMD< 10% was based
on the observations of other studies. Kuvin et al. demonstrated
that 10% as a cutoff value of FMD on ROC curve was asso-
ciated with the highest predictivity of CAD.12 Shechter et al.
reported that a median FMD of 10.7% was the best indepen-
dent predictor of long-term cardiovascular adverse events.13
Lower cutoff values are expected if the sphygmomanometer
cuff occlusion was done below the antecubital fossa or in the
elderly.22 However, there is no current agreement regarding a
cutoff value of FMD or an accurate deﬁnition of endothelial
dysfunction.
In the present study, WP and cigarette smoking were
associated with a signiﬁcantly lower FMD and a higher num-
ber of subjects with endothelial dysfunction respectively. In
other studies, cigarette smoking has been associated with a
reduced FMD and endothelial dysfunction.23,24 This is likely
mediated by a decreased nitric oxide bioavailability due to
the effect of free radicals, tar, nicotine, polycyclic aromatic
hydrocarbons, heavy metals and other toxic components.7
Regarding whether this can be applied to WP smoking, to
our knowledge, little data are available. Rammaha et al. stud-
ied the effect of apple ﬂavored water pipe smoke condensate
on human endothelial cells in vitro.25 WP smoke induced cell
cycle arrest, apoptosis, oxidative stress, decreased NO activity,
impaired vasodilatation, and inﬂammation. Although, it is
unknown if the smoke concentration used in their study is sim-
ilar to that in in vivo, our ﬁndings support these observations.
Aging is an important risk factor for many cardiovascular
diseases, with increasing inﬂammation,26 and progressive
decline of endothelial function.27 In a study,28 FMD was lower
in older than younger healthy men, that was attributed to a
greater expression of endothelin-1 in endothelial cells and
increased oxidative stress due to increased expression of oxi-
dant-generating enzymes, such as NADPH oxidase, xanthine
oxidase and uncoupled endothelial NO synthase.29,30 In agree-
ment with this, in the present study, age was an independent
predictor for endothelial dysfunction.
Although the link between inﬂammation and endothelial
dysfunction has been described in clinical and experimental
studies,31,32 we did not ﬁnd a direct correlation between hs-
CRP and FMD. Such correlation may be better observed in
the presence of DM, obesity, or CAD than healthy individuals.
Assessment of other inﬂammatory biomarkers might be more
informative which was not done in our study.
4.4. Water pipe smoking versus cigarette smoking
On univariate analysis, we demonstrate that the effect of WP
smoking on hs-CRP and FMD was similar to that of cigarette
smoking. However, since there are other possible confounding
variables such as age, blood pressure, and BMI, we included
them in an adjusted regression model. As inﬂammation andendothelial dysfunction play a pivotal role in atherosclerosis
and plaque vulnerability, our endpoint was the composite of
high risk hs-CRP level (>3 mg/l) and endothelial dysfunction
(FMD< 10%) which occurred in 34 subjects. Such high risk
proﬁle has been reported to be associated with a higher rate
of cardiovascular events in several studies.8,9,11,12,22,26 We
found that cigarette smoking (P= 0.046) and increasing age
(P= 0.002) were the only signiﬁcant predictors for high risk
proﬁle in adjusted regression model, whereas WP smoking
had no predictive effect (P= 0.91). This may indicate that
WP smoking is less likely than cigarette smoking to predict
high likelihood of cardiac events.
There is some evidence that WP smoking was less hazard-
ous than cigarette smoking. Twenty-four studies on WP smok-
ing were reviewed by Akl et al.33 In contrast to cigarette
smoking, WP smoking was not signiﬁcantly associated with
bladder cancer (OR = 0.8, 95% CI 0.2–4.0), esophageal can-
cer (OR = 1.85, 95% CI 0.95–3.58), oral dysplasia
(OR = 8.33, 95% CI 0.78–9.47) or infertility (OR = 2.5,
95% CI 1.0–6.3). In a similar context, we demonstrate that
the cardiovascular risk associated with WP smoking and ciga-
rette smoking is not the same. Our ﬁnding should not encour-
age WP smoking habit as it is still associated with a lower
FMD compared to non smokers (P= 0.035). In other words,
apple ﬂavored WP smoking did not predict high risk, but was
associated with a signiﬁcant risk.
Several in vitro and experimental studies compared WP to
cigarette smoke. Expired-air carbon monoxide (CO) concen-
tration was found to be higher in WP smokers than cigarette
smokers.34 However, although an earlier study suggested that
CO could be responsible for cardiovascular hazards,35 more
recent data suggest that CO was an unlikely cause for athero-
sclerosis or thrombosis.36–38 Nicotine was found to be 10 times
higher in WP smoke than cigarette smoke.39 However, the
majority of current evidence suggests that nicotine has a minor
effect on the initiation or progression of atherosclerosis and
thrombosis.40–43 Some studies demonstrated that the overall
toxic components of WP smoke and cigarette smoke are com-
parable.34,39 One study compared the effect of WP smoke to
cigarette smoke on mice and found similar degrees of inﬂam-
mation and oxidative stress.44 These data spoke against the
concept that WP smoking is more dangerous than cigarette
smoking.
In a recent study, Selim et al.45 found that the extent of
CAD assessed by the Duke jeopardy score was worse in WP
smokers than cigarette smokers. Authors explained their ﬁnd-
ings by the higher prevalence of CAD risk factors among the
WP smoker group. The heterogeneity of demographic and
clinical characteristics of their study sample, and the inclusion
of both ﬂavored and non ﬂavored WP tobacco would necessi-
tate multivariate analysis which was not done. This further
questions the sole impact of apple ﬂavored WP smoking on
atherosclerosis compared to cigarette smoking.
Up to our knowledge, the current study is the ﬁrst to com-
pare apple ﬂavored WP smoking to cigarette smoking regard-
ing the effect on inﬂammation and endothelial dysfunction in
healthy male smokers, and the ﬁrst to conclude that cigarette
smoking is a more powerful predictor for a high cardiovascu-
lar risk than WP smoking. This would provoke the need for
further studies.
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Neither the rate of smoking, smoking duration, nor number of
totally smoked WPHs/cigarettes could predict the composite
of high risk hs-CRP and endothelial dysfunction on regression
analysis in the current study. However, on separate correla-
tions with either hs-CRP or FMD, WP smoking duration
had linear correlation with FMD but not with hs-CRP, while
cigarette smoking had cumulative effect on hs-CRP but not on
FMD. In accordance with our ﬁndings, other studies demon-
strated that cigarette smoking had a dose-dependent correla-
tion with CRP level,15 but did not have linear effect on
endothelial function.46,47 Regarding WP smoking, one study
demonstrated a dose–response relationship between WP smok-
ing duration and severity of coronary artery stenosis.48 The
preferential correlation of duration of WP smoking with
FMD and duration of cigarette smoking with hs-CRP in our
study may indicate that the mechanism of cumulative injury
is not the same. This demands the need for further compara-
tive studies.
5. Limitations
In addition to the relatively small study sample, we could not
rule out passive smoking among the non smoker group. We
assessed hs-CRP by one blood sample which might not repre-
sent the variable plasma hs-CRP level. The method of measur-
ing FMD needs further standardization.
6. Conclusion
Smoking was associated with a modest elevation in hs-CRP
and signiﬁcant reduction in FMD. The effect of WP smoking
and cigarette smoking on hs-CRP and endothelial function
was comparable. On multivariate analysis, cigarette but not
WP smoking, and increasing age were independently associ-
ated with the composite of a high risk hs-CRP level and endo-
thelial dysfunction. WP and cigarette smoking had a
cumulative effect on FMD and hs-CRP respectively. Further
studies are needed to verify these ﬁndings.
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